149 related articles for article (PubMed ID: 12615444)
41. Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.
Huang Y; Cyr SL; Burt DS; Anderson R
J Clin Virol; 2009 Apr; 44(4):287-91. PubMed ID: 19233722
[TBL] [Abstract][Full Text] [Related]
42. Liposome encapsulation of a soluble recombinant fragment of the respiratory syncytial virus (RSV) G protein enhances immune protection and reduces lung eosinophilia associated with virus challenge.
Mader D; Huang Y; Wang C; Fraser R; Issekutz AC; Stadnyk AW; Anderson R
Vaccine; 2000 Jan; 18(11-12):1110-7. PubMed ID: 10590333
[TBL] [Abstract][Full Text] [Related]
43. Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone.
Schmidt AC; Wenzke DR; McAuliffe JM; St Claire M; Elkins WR; Murphy BR; Collins PL
J Virol; 2002 Feb; 76(3):1089-99. PubMed ID: 11773385
[TBL] [Abstract][Full Text] [Related]
44. Cytotoxic T cell activity against the 22-kDa protein of human respiratory syncytial virus (RSV) is associated with a significant reduction in pulmonary RSV replication.
Nicholas JA; Rubino KL; Levely ME; Meyer AL; Collins PL
Virology; 1991 Jun; 182(2):664-72. PubMed ID: 2024493
[TBL] [Abstract][Full Text] [Related]
45. The pulmonary immune response of Balb/c mice vaccinated with the fusion protein of respiratory syncytial virus.
Hancock GE; Hahn DJ; Speelman DJ; Hildreth SW; Pillai S; McQueen K
Vaccine; 1994; 12(3):267-74. PubMed ID: 8165859
[TBL] [Abstract][Full Text] [Related]
46. Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein.
Fonseca DP; Benaissa-Trouw B; van Engelen M; Kraaijeveld CA; Snippe H; Verheul AF
Infect Immun; 2001 Aug; 69(8):4839-45. PubMed ID: 11447158
[TBL] [Abstract][Full Text] [Related]
47. Major histocompatibility complex-dependent cytotoxic T lymphocyte repertoire and functional avidity contribute to strain-specific disease susceptibility after murine respiratory syncytial virus infection.
Jessen B; Faller S; Krempl CD; Ehl S
J Virol; 2011 Oct; 85(19):10135-43. PubMed ID: 21795345
[TBL] [Abstract][Full Text] [Related]
48. Protective efficacy and immunogenicity of a combinatory DNA vaccine against Influenza A Virus and the Respiratory Syncytial Virus.
Stab V; Nitsche S; Niezold T; Storcksdieck Genannt Bonsmann M; Wiechers A; Tippler B; Hannaman D; Ehrhardt C; Uberla K; Grunwald T; Tenbusch M
PLoS One; 2013; 8(8):e72217. PubMed ID: 23967287
[TBL] [Abstract][Full Text] [Related]
49. Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine.
An LL; Rodriguez F; Harkins S; Zhang J; Whitton JL
Vaccine; 2000 Apr; 18(20):2132-41. PubMed ID: 10715528
[TBL] [Abstract][Full Text] [Related]
50. Respiratory syncytial virus infection of gene gun vaccinated mice induces Th2-driven pulmonary eosinophilia even in the absence of sensitisation to the fusion (F) or attachment (G) protein.
Bembridge GP; Rodriguez N; Garcia-Beato R; Nicolson C; Melero JA; Taylor G
Vaccine; 2000 Dec; 19(9-10):1038-46. PubMed ID: 11137237
[TBL] [Abstract][Full Text] [Related]
51. Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice.
Boelen A; Andeweg A; Kwakkel J; Lokhorst W; Bestebroer T; Dormans J; Kimman T
Vaccine; 2000 Nov; 19(7-8):982-91. PubMed ID: 11115725
[TBL] [Abstract][Full Text] [Related]
52. Protection against respiratory syncytial virus (RSV) elicited in mice by plasmid DNA immunisation encoding a secreted RSV G protein-derived antigen.
Andersson C; Liljeström P; Ståhl S; Power UF
FEMS Immunol Med Microbiol; 2000 Dec; 29(4):247-53. PubMed ID: 11118904
[TBL] [Abstract][Full Text] [Related]
53. Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine.
Xu W; Chu Y; Zhang R; Xu H; Wang Y; Xiong S
Virology; 2005 Apr; 334(2):255-63. PubMed ID: 15780875
[TBL] [Abstract][Full Text] [Related]
54. Enhanced humoral and CD8+ T cell immunity in mice vaccinated by DNA vaccine against human respiratory syncytial virus through targeting the encoded F protein to dendritic cells.
Hua Y; Jiao YY; Ma Y; Peng XL; Fu YH; Zhang XJ; Zheng YB; Zheng YP; Hong T; He JS
Int Immunopharmacol; 2017 May; 46():62-69. PubMed ID: 28259002
[TBL] [Abstract][Full Text] [Related]
55. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes.
Kuhröber A; Wild J; Pudollek HP; Chisari FV; Reimann J
Int Immunol; 1997 Aug; 9(8):1203-12. PubMed ID: 9263018
[TBL] [Abstract][Full Text] [Related]
56. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
[TBL] [Abstract][Full Text] [Related]
57. Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines.
Crowe JE; Firestone CY; Murphy BR
J Immunol; 2001 Oct; 167(7):3910-8. PubMed ID: 11564809
[TBL] [Abstract][Full Text] [Related]
58. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
Morello CS; Cranmer LD; Spector DH
J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
[TBL] [Abstract][Full Text] [Related]
59. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
Shi L; Liu S; Fan GX; Sheng L; Ren HX; Yuan YK
Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665
[TBL] [Abstract][Full Text] [Related]
60. Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity.
Sarkar I; Garg R; van Drunen Littel-van den Hurk S
Vaccine; 2016 Sep; 34(42):5114-5124. PubMed ID: 27591951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
